Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.
Medscape Medical News
Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.
Medscape Medical News